These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3381151)

  • 1. Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern Africa.
    Rossouw JE; Steyn K; Berger GM; Vermaak WJ; Kock J; Seftel HC; Gevers W
    S Afr Med J; 1988 Jun; 73(12):693-700. PubMed ID: 3381151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum total and high-density lipoprotein cholesterol--reference values obtained in the Coronary Risk Factor Study baseline survey.
    Rossouw JE; Jooste PL; Steyn K; Benadé AJ
    S Afr Med J; 1985 Apr; 67(14):533-8. PubMed ID: 3992377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological reference ranges for low-density lipoprotein cholesterol and apolipoprotein B for identification of increased risk of ischaemic heart disease.
    Vermaak WJ; Kotze JP; van der Merwe AM; Becker PJ; Ubbink JB; Barnard HC; Roux FG; Schoeman JJ; Strydom GL
    S Afr Med J; 1991 Apr; 79(7):367-71. PubMed ID: 2014459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.
    Steyn K; Goldberg YP; Kotze MJ; Steyn M; Swanepoel AS; Fourie JM; Coetzee GA; Van der Westhuyzen DR
    Hum Genet; 1996 Oct; 98(4):479-84. PubMed ID: 8792826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease risk factors among blood donors in northwest Ethiopia.
    Gebre-Yohannes A; Rahlenbeck SI
    East Afr Med J; 1998 Sep; 75(9):495-500. PubMed ID: 10493048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for coronary heart disease risk in the elderly: total cholesterol versus high-density lipoprotein-cholesterol.
    Kligman EW; Watkins AJ
    Am J Prev Med; 1991; 7(5):263-7. PubMed ID: 1790030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease.
    Tonstad S; Sundfør T; Seljeflot I
    Am J Cardiol; 2005 May; 95(10):1187-91. PubMed ID: 15877991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
    Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
    Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1988 May; 9(5):571-600. PubMed ID: 3402474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.
    Alessandri C; Basili S; Peverini F; Barsi R; Paradiso M; Coppotelli L; Violi F; Cordova C
    Clin Ter; 1992 Aug; 141(8):109-14. PubMed ID: 1395453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
    Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.